LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 513 | 677 | 10349 | 0.0654 | 0.0659 |
| BT-20 | XMD11-85h | 0.04 | uM | LJP6 | 3 | P24 | 72 | hr | 1657 | 4599 | 5546 | 0.8292 | 0.7962 |
| SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1476 | 2426 | 3788 | 0.6403 | 0.4408 |
| SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1476 | 2532 | 3731 | 0.6786 | 0.4966 |
| SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1476 | 2320 | 3796 | 0.6111 | 0.3932 |
| MDA-MB-231 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 868 | 1094 | 3440 | 0.3180 | 0.1235 |